PTPRC and acute myeloid leukemia: These epitope-edited CD45-CAR-T cells exhibited fratricide resistance and efficacy against PDX AML.361 Thus, ex vivo epitope editing in HSCs and T cells could revolutionize CAR-T cell therapies for AML, offering a promising strategy to enhance treatment effectiveness and durability.